BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luk C, Jones S, Thomas C, Fox NC, Mok TH, Mead S, Collinge J, Jackson GS. Diagnosing Sporadic Creutzfeldt-Jakob Disease by the Detection of Abnormal Prion Protein in Patient Urine. JAMA Neurol 2016;73:1454-60. [PMID: 27699415 DOI: 10.1001/jamaneurol.2016.3733] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Yoon S, Go G, Yoon Y, Lim J, Lee G, Lee S. Harnessing the Physiological Functions of Cellular Prion Protein in the Kidneys: Applications for Treating Renal Diseases. Biomolecules 2021;11:784. [PMID: 34067472 DOI: 10.3390/biom11060784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Hermann P, Appleby B, Brandel JP, Caughey B, Collins S, Geschwind MD, Green A, Haïk S, Kovacs GG, Ladogana A, Llorens F, Mead S, Nishida N, Pal S, Parchi P, Pocchiari M, Satoh K, Zanusso G, Zerr I. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol 2021;20:235-46. [PMID: 33609480 DOI: 10.1016/S1474-4422(20)30477-4] [Cited by in Crossref: 68] [Cited by in F6Publishing: 49] [Article Influence: 34.0] [Reference Citation Analysis]
3 Douet JY, Huor A, Cassard H, Lugan S, Aron N, Arnold M, Vilette D, Torres JM, Ironside JW, Andreoletti O. Wide distribution of prion infectivity in the peripheral tissues of vCJD and sCJD patients. Acta Neuropathol 2021;141:383-97. [PMID: 33532912 DOI: 10.1007/s00401-021-02270-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
4 Moudjou M, Castille J, Passet B, Herzog L, Reine F, Vilotte JL, Rezaei H, Béringue V, Igel-Egalon A. Improving the Predictive Value of Prion Inactivation Validation Methods to Minimize the Risks of Iatrogenic Transmission With Medical Instruments. Front Bioeng Biotechnol 2020;8:591024. [PMID: 33335894 DOI: 10.3389/fbioe.2020.591024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Ascari LM, Rocha SC, Gonçalves PB, Vieira TCRG, Cordeiro Y. Challenges and Advances in Antemortem Diagnosis of Human Transmissible Spongiform Encephalopathies. Front Bioeng Biotechnol 2020;8:585896. [PMID: 33195151 DOI: 10.3389/fbioe.2020.585896] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
6 Knight R. Clinical diagnosis of human prion disease. Prog Mol Biol Transl Sci 2020;175:1-18. [PMID: 32958229 DOI: 10.1016/bs.pmbts.2020.07.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Eraña H, Charco JM, González-Miranda E, García-Martínez S, López-Moreno R, Pérez-Castro MA, Díaz-Domínguez CM, García-Salvador A, Castilla J. Detection of Pathognomonic Biomarker PrPSc and the Contribution of Cell Free-Amplification Techniques to the Diagnosis of Prion Diseases. Biomolecules 2020;10:E469. [PMID: 32204429 DOI: 10.3390/biom10030469] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
8 Tee BL, Longoria Ibarrola EM, Geschwind MD. Prion Diseases. Neurol Clin 2018;36:865-97. [PMID: 30366560 DOI: 10.1016/j.ncl.2018.07.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 8.5] [Reference Citation Analysis]
9 Appleby BS, Rhoads DD, Mente K, Cohen ML. A Practical Primer on Prion Pathology. J Neuropathol Exp Neurol 2018;77:346-52. [PMID: 29608707 DOI: 10.1093/jnen/nly019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
10 Camacho MV, Telling G, Kong Q, Gambetti P, Notari S. Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification. Lab Invest 2019;99:1741-8. [PMID: 31249376 DOI: 10.1038/s41374-019-0282-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
11 Cali I, Lavrich J, Moda F, Kofskey D, Nemani SK, Appleby B, Tagliavini F, Soto C, Gambetti P, Notari S. PMCA-replicated PrPD in urine of vCJD patients maintains infectivity and strain characteristics of brain PrPD: Transmission study. Sci Rep 2019;9:5191. [PMID: 30914754 DOI: 10.1038/s41598-019-41694-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
12 Alpert JN. Evaluation of the Poorly Responsive Patient. The Neurologic Diagnosis 2019. [DOI: 10.1007/978-3-319-95951-1_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Alpert JN. Diagnostic Dilemmas. The Neurologic Diagnosis 2019. [DOI: 10.1007/978-3-319-95951-1_12] [Reference Citation Analysis]
14 Thompson AGB, Mead SH. Review: Fluid biomarkers in the human prion diseases. Mol Cell Neurosci 2019;97:81-92. [PMID: 30529227 DOI: 10.1016/j.mcn.2018.12.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
15 Nihat A, Mead S. Detection of Creutzfeldt-Jakob disease prions in skin: implications for healthcare. Genome Med 2018;10:22. [PMID: 29580258 DOI: 10.1186/s13073-018-0536-3] [Reference Citation Analysis]
16 Bett C, Piccardo P, Cervenak J, Torres JM, Asher DM, Gregori L. Both murine host and inoculum modulate expression of experimental variant Creutzfeldt-Jakob disease. J Gen Virol 2018;99:422-33. [PMID: 29458529 DOI: 10.1099/jgv.0.001017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
17 Candelise N, Schmitz M, Da Silva Correia SM, Arora AS, Villar-Piqué A, Zafar S, Llorens F, Cramm M, Zerr I. Applications of the real-time quaking-induced conversion assay in diagnosis, prion strain-typing, drug pre-screening and other amyloidopathies. Expert Rev Mol Diagn 2017;17:897-904. [PMID: 28817974 DOI: 10.1080/14737159.2017.1368389] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
18 Bistaffa E, Rossi M, De Luca CMG, Moda F. Biosafety of Prions. Prog Mol Biol Transl Sci 2017;150:455-85. [PMID: 28838674 DOI: 10.1016/bs.pmbts.2017.06.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
19 Mead S, Rudge P. CJD mimics and chameleons. Pract Neurol 2017;17:113-21. [PMID: 28153848 DOI: 10.1136/practneurol-2016-001571] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 7.5] [Reference Citation Analysis]
20 Gaudino S, Gangemi E, Colantonio R, Botto A, Ruberto E, Calandrelli R, Martucci M, Vita MG, Masullo C, Cerase A, Colosimo C. Neuroradiology of human prion diseases, diagnosis and differential diagnosis. Radiol Med 2017;122:369-85. [PMID: 28110369 DOI: 10.1007/s11547-017-0725-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]